IPO - PALATIN TECHNOLOGIES INC

Form Type: 424B4

Filing Date: 2025-05-08

Corporate Action: Ipo

Type: New

Accession Number: 000165495425005297

Filing Summary: On May 8, 2025, Palatin Technologies Inc. filed a prospectus for an IPO, offering 7,324,119 shares of Common Stock alongside Series F and G Common Warrants. Each share is priced at $0.15, with a combined offering expected to yield approximately $1,021,714.60 before expenses. The Series F Warrants have an exercise price of $0.30, while Series G Warrants are priced at $0.15. The offering is engaged through A.G.P./Alliance Global Partners as the lead placement agent. Significant risks include potential non-compliance with NYSE American listing requirements and uncertainties regarding future financing. Delivery of the securities is scheduled on or about May 8, 2025. The offering will terminate on May 30, 2025. Investors should review risks associated with the investment carefully, as there's no guarantee that the offering will fully meet financial objectives. The company's ability to maintain listing on NYSE American is currently in jeopardy due to historical non-compliance.

Form Type: CORRESP

Filing Date: 2025-05-02

Corporate Action: Ipo

Type: New

Accession Number: 000165495425005068

Filing Summary: Palatin Technologies, Inc. submitted a request to the U.S. Securities and Exchange Commission (SEC) to have its Registration Statement on Form S-1 (File No. 333-286280) declared effective. The request seeks to make the registration effective on May 5, 2025, at 5:00 p.m. Eastern Time. The company emphasizes that it will notify the SEC if there are changes to this timeline. The request indicates an initiation of the initial public offering (IPO) process for the company, reflecting significant corporate developments.

Form Type: CORRESP

Filing Date: 2025-04-10

Corporate Action: Ipo

Type: New

Accession Number: 000165495425004129

Filing Summary: Palatin Technologies, Inc. has submitted a request to the U.S. Securities and Exchange Commission for the effectiveness of its Registration Statement on Form S-1, pertaining to its initial public offering (IPO). The Company has requested the Registration Statement to become effective on April 14, 2025, at 5:00 p.m. Eastern Time. In case of any inquiries, the outside counsel for the Company, Faith L. Charles from Thompson Hine LLP, is available for contact.

Form Type: CORRESP

Filing Date: 2025-04-10

Corporate Action: Ipo

Type: New

Accession Number: 000165495425004131

Filing Summary: Palatin Technologies, Inc. has filed a correspondence with the U.S. Securities and Exchange Commission regarding its Registration Statement on Form S-1, with file number 333-286280. The document is a request for the acceleration of the effective date of the registration statement to 5:00 p.m. Eastern Time on April 14, 2025. The request is made by A.G.P. / Alliance Global Partners, acting as the Lead Placement Agent. The correspondence is signed by Thomas J. Higgins, Managing Director at Alliance Global Partners.

Form Type: CORRESP

Filing Date: 2025-04-02

Corporate Action: Ipo

Type: Update

Accession Number: 000165495425003841

Filing Summary: Palatin Technologies, Inc. has formally withdrawn its request for acceleration of the effective date of its registration statement on Form S-1. This decision was communicated to the U.S. Securities and Exchange Commission in a letter dated April 2, 2025, where the company stated that it is no longer seeking to have the registration statement declared effective at this time, which was initially requested for April 2, 2025, at 5:00 p.m., Eastern Time. The correspondence includes acknowledgment of a previous letter filed on March 31, 2025, regarding this request. A.G.P./Alliance Global Partners, the Lead Placement Agent for the offering, signs off this correspondence with Thomas J. Higgins as the Managing Director.

Form Type: CORRESP

Filing Date: 2025-04-02

Corporate Action: Ipo

Type: New

Accession Number: 000165495425003854

Filing Summary: Palatin Technologies, Inc. has submitted a request to the U.S. Securities and Exchange Commission to make their Registration Statement on Form S-1 (File No. 333-286280) effective on April 3, 2025, at 5:00 p.m. Eastern Time. This request is in accordance with Rule 461 of the Securities Act of 1933. The company has provided contact details for their outside counsel, Faith L. Charles, for any inquiries regarding the request, and has requested confirmation once the Registration Statement is declared effective.

Form Type: S-1

Filing Date: 2025-03-31

Corporate Action: Ipo

Type: New

Accession Number: 000165495425003691

Filing Summary: Palatin Technologies, Inc., a biopharmaceutical company, filed a registration statement under the Securities Act of 1933 on March 31, 2025, in preparation for an initial public offering (IPO) of its securities. The company is offering up to 17,317,816 shares of its common stock alongside common warrants and pre-funded warrants. The combined public offering price for each share of common stock and accompanying common warrant was initially set at $0.7218, based on the market closing price prior to the offering. The prospectus outlines certain aspects of the company's financial status and its ongoing efforts in drug development, particularly focusing on products utilizing the melanocortin receptor system to treat various diseases including obesity and dry eye disease. The company acknowledges operational challenges and risks, notably the uncertainty of achieving profitability and maintaining compliance with NYSE listing standards. Significant details include the engagement of A.G.P./Alliance Global Partners and Laidlaw & Company as the Placement Agents, the anticipated use of proceeds from the offering, and the need for substantial additional financing to continue operations. The offering is set to terminate on April 25, 2025, unless otherwise decided by the company.

Form Type: CORRESP

Filing Date: 2025-03-31

Corporate Action: Ipo

Type: New

Accession Number: 000165495425003721

Filing Summary: Palatin Technologies, Inc. has submitted a request for the U.S. Securities and Exchange Commission to declare its Registration Statement on Form S-1 (File No. 333-286280) effective on April 2, 2025, at 5:00 p.m. Eastern Time. This action indicates the company is moving forward with its initial public offering (IPO) plans. The request is made under Rule 461 of the Securities Act of 1933. The company's contact for this matter is Faith L. Charles from Thompson Hine LLP, who can be reached for inquiries and updates on the registration status.

Form Type: DRS

Filing Date: 2025-03-07

Corporate Action: Ipo

Type: New

Accession Number: 000165495425002400

Filing Summary: Palatin Technologies, Inc. is planning to offer up to 16,666,667 shares of common stock and related Series F common warrants, alongside pre-funded warrants in a proposed public offering. The offering’s estimated public offering price is $0.90 per share, based on the recent closing price of its common stock on NYSE American. The company will engage A.G.P. and Laidlaw as placement agents. The securities being offered are subject to various conditions, including a continuous offering under Rule 415. The cash fees payable to the placement agents are set at 7.0% of the aggregate purchase price paid by investors. The company states that it has significant operating losses and expresses concern for future financing. With no minimum offering amount required, there’s uncertainty about proceeds and business goals. The company also acknowledges compliance issues with NYSE American listing requirements and is actively working on plans for regaining compliance. This IPO is aimed at raising capital for its product development initiatives, particularly for pharmaceuticals targeting significant unmet medical needs. Investors are advised to consider associated risks thoroughly before participating.